These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14599094)

  • 1. Pyrimidine nucleoside analogs in cancer treatment.
    Galmarini CM; Jordheim L; Dumontet C
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):717-28. PubMed ID: 14599094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside analogues and nucleobases in cancer treatment.
    Galmarini CM; Mackey JR; Dumontet C
    Lancet Oncol; 2002 Jul; 3(7):415-24. PubMed ID: 12142171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.
    Zhang J; Visser F; King KM; Baldwin SA; Young JD; Cass CE
    Cancer Metastasis Rev; 2007 Mar; 26(1):85-110. PubMed ID: 17345146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New nucleoside analogs in the treatment of hematological disorders.
    Szafraniec SI; Stachnik KJ; Skierski JS
    Acta Pol Pharm; 2004; 61(3):223-32. PubMed ID: 15481249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
    Galmarini CM; Popowycz F; Joseph B
    Curr Med Chem; 2008; 15(11):1072-82. PubMed ID: 18473803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New nucleoside analogs in the treatment of solid tumors.
    Szafraniec SI; Stachnik KJ; Skierski JS
    Acta Pol Pharm; 2004; 61(4):297-305. PubMed ID: 15575597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.
    Damaraju VL; Damaraju S; Young JD; Baldwin SA; Mackey J; Sawyer MB; Cass CE
    Oncogene; 2003 Oct; 22(47):7524-36. PubMed ID: 14576856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside transporters: biological insights and therapeutic applications.
    Choi JS; Berdis AJ
    Future Med Chem; 2012 Jul; 4(11):1461-78. PubMed ID: 22857534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine nucleoside antimetabolites in development for the treatment of cancer.
    Parker WB; Secrist JA; Waud WR
    Curr Opin Investig Drugs; 2004 Jun; 5(6):592-6. PubMed ID: 15242246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human nucleoside transporters: biomarkers for response to nucleoside drugs.
    Damaraju VL; Sawyer MB; Mackey JR; Young JD; Cass CE
    Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):450-63. PubMed ID: 20183595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1.
    Chang C; Swaan PW; Ngo LY; Lum PY; Patil SD; Unadkat JD
    Mol Pharmacol; 2004 Mar; 65(3):558-70. PubMed ID: 14978234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine and pyrimidine nucleoside analogs.
    Plunkett W; Gandhi V
    Cancer Chemother Biol Response Modif; 2001; 19():21-45. PubMed ID: 11686015
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of nucleoside transporters using novel autofluorescent nucleoside probes.
    Zhang J; Sun X; Smith KM; Visser F; Carpenter P; Barron G; Peng Y; Robins MJ; Baldwin SA; Young JD; Cass CE
    Biochemistry; 2006 Jan; 45(4):1087-98. PubMed ID: 16430205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nucleoside transporters in nucleoside-derived drug sensitivity.
    Molina-Arcas M; Pastor-Anglada M
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):335-46. PubMed ID: 20544517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies.
    Fernández-Calotti PX; Colomer D; Pastor-Anglada M
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1324-40. PubMed ID: 22132993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents.
    Von Hoff DD; Rozencweig M; Soper WT; Helman LJ; Penta JS; Davis HL; Muggia FM
    Cancer Treat Rep; 1977 Aug; 61(5):759-68. PubMed ID: 890691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants.
    Solaroli N; Johansson M; Balzarini J; Karlsson A
    Gene Ther; 2007 Jan; 14(1):86-92. PubMed ID: 16885999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Troxacitabine].
    Gourdeau H; Jolivet J
    Bull Cancer; 2004 Mar; 91(3):213-8. PubMed ID: 15171046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Bacillus anthracis thymidine kinase as a potential target for the development of antibacterial nucleoside analogs.
    Carnrot C; Vogel SR; Byun Y; Wang L; Tjarks W; Eriksson S; Phipps AJ
    Biol Chem; 2006 Dec; 387(12):1575-81. PubMed ID: 17132103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy.
    Bronckaers A; Balzarini J; Liekens S
    Biochem Pharmacol; 2008 Jul; 76(2):188-97. PubMed ID: 18555978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.